Update From Dermatology Nurses’ Association Convention 2025

    Angela L. Borger
    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Spironolactone →

    powerful topical and oral anti-androgen used mostly by women

    Studysummary This article reports on the 2025 Annual Dermatology Nurses’ Association Convention, emphasizing its role in education, networking, and advocacy advice, and provides insights into managing stress-related skin issues and hair loss, as well as dermatology treatment advances.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The Dermatology Nurses’ Association Annual Convention 2025 emphasized the importance of advocacy, mental health, and stress management in dermatological care. It highlighted the prevalence of hair loss conditions like telogen effluvium and androgenetic alopecia, discussing treatments such as minoxidil and spironolactone. The convention also addressed the psychosocial impact of skin diseases, the need for diversity in dermatology, and advancements in treatments for psoriasis and atopic dermatitis. The event underscored the significance of empathy, patient education, and collaboration in dermatology nursing. Joan Pohutsky joined the JDNA Editorial Board to further education and research in the field.
    Discuss this study in the Community →